v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development (including $15 and $13 for a related party) $ 7,572 $ 6,030
General and administrative (including $73 and $151 for a related party) 4,261 4,324
Total operating expenses 11,833 10,354
Loss from operations (11,833) (10,354)
Other income (expense), net:    
Change in fair value of tranche liability (including $0 and $331 for a related party) 0 365
Change in fair value of derivative liabilities (including $0 and $1,165 for a related party) 0 1,229
Interest expense (including $0 and $1,384 for a related party) 0 (1,443)
Loss on extinguishment and on issuance of convertible promissory notes (including $0 and $169 for a related party) 0 (186)
Other income, net 977 193
Total other income, net 977 158
Net loss $ (10,856) $ (10,196)
Net loss per share attributable to common stockholders - basic $ (0.46) $ (2.52)
Net loss per share attributable to common stockholders - diluted $ (0.46) $ (2.52)
Weighted-average shares outstanding - basic 23,723,618 4,053,140
Weighted-average shares outstanding - diluted 23,723,618 4,053,140
Comprehensive loss:    
Net loss $ (10,856) $ (10,196)
Other comprehensive income (loss):    
Unrealized loss on marketable securities, net of tax (55) 0
Total other comprehensive loss (55) 0
Comprehensive loss $ (10,911) $ (10,196)